| 000 | 01139 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517025002.0 | ||
| 264 | 0 | _c20151230 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a1873-4316 | ||
| 024 | 7 |
_a10.2174/138920101606150407112646 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Yong-Tang | |
| 245 | 0 | 0 |
_aImmunotherapy strategies for spinal cord injury. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical biotechnology _c2015 |
||
| 300 |
_a492-505 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunization _xmethods |
| 650 | 0 | 4 |
_aNeuroprotective Agents _ximmunology |
| 650 | 0 | 4 |
_aSpinal Cord _xdrug effects |
| 650 | 0 | 4 |
_aSpinal Cord Injuries _ximmunology |
| 700 | 1 | _aLu, Xiu-Min | |
| 700 | 1 | _aChen, Kai-Ting | |
| 700 | 1 | _aShu, Ya-Hai | |
| 700 | 1 | _aQiu, Chun-Hong | |
| 773 | 0 |
_tCurrent pharmaceutical biotechnology _gvol. 16 _gno. 6 _gp. 492-505 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/138920101606150407112646 _zAvailable from publisher's website |
| 999 |
_c24791145 _d24791145 |
||